One hundred years after the Spanish flu pandemic, Marsh and Munich Re, in May 2018, launched an innovative parametric insurance product, PathogenRX. This provided insurance against business interruption caused by a pandemic. In October 2018, Marsh presciently observed in a paper entitled “Pandemic Readiness: Risk Finance and Mitigation Strategies”: “Although recent pandemics and epidemics have